Point72 Asset Management L.P. Has $274,000 Stock Holdings in Definitive Healthcare Corp. (NASDAQ:DH)

Point72 Asset Management L.P. cut its position in Definitive Healthcare Corp. (NASDAQ:DH - Free Report) by 71.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 61,300 shares of the company's stock after selling 151,809 shares during the quarter. Point72 Asset Management L.P. owned 0.05% of Definitive Healthcare worth $274,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Massachusetts Financial Services Co. MA raised its holdings in Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company's stock worth $27,058,000 after purchasing an additional 1,626,813 shares in the last quarter. Millennium Management LLC acquired a new stake in shares of Definitive Healthcare during the second quarter worth $9,283,000. Granite Investment Partners LLC boosted its holdings in shares of Definitive Healthcare by 22.5% in the second quarter. Granite Investment Partners LLC now owns 884,872 shares of the company's stock valued at $4,831,000 after acquiring an additional 162,432 shares in the last quarter. 272 Capital LP acquired a new position in Definitive Healthcare during the 2nd quarter worth approximately $3,480,000. Finally, Victory Capital Management Inc. grew its holdings in Definitive Healthcare by 6.5% during the third quarter. Victory Capital Management Inc. now owns 542,170 shares of the company's stock worth $2,424,000 after acquiring an additional 33,161 shares during the period. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Definitive Healthcare Stock Performance

Shares of NASDAQ:DH traded down $0.01 on Friday, hitting $4.49. 210,901 shares of the company were exchanged, compared to its average volume of 721,441. The company's 50 day moving average price is $4.41 and its two-hundred day moving average price is $4.72. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The firm has a market capitalization of $518.68 million, a price-to-earnings ratio of -1.45, a PEG ratio of 3.29 and a beta of 1.40. Definitive Healthcare Corp. has a one year low of $3.19 and a one year high of $10.62.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. BTIG Research began coverage on shares of Definitive Healthcare in a report on Tuesday, September 17th. They issued a "buy" rating and a $7.00 target price on the stock. Needham & Company LLC reissued a "hold" rating on shares of Definitive Healthcare in a research report on Friday, November 8th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $5.81.

Insider Activity at Definitive Healthcare

In other news, insider William Moschella sold 45,000 shares of the company's stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total transaction of $211,500.00. Following the transaction, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. This represents a 9.40 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 14.84% of the stock is owned by insiders.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.